Buckthorn extract (Frangulae extract)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceBuckthorn aldersBuckthorn alders
Similar drugsTo uncover
  • Buckthorn Buckthorn
    powdercompilation of plants. inwards 
    LEK S +, LLC     Russia
  • Buckthorn Buckthorn
    powderraw materials. inwards 
    HEALTH OF THE FIRM, LLC     Russia
  • Buckthorn Buckthorn
    powderraw materials. inwards 
    KRASNOHORSKILKLEKSSREDSTVA, JSC     Russia
  • Buckthorn Buckthorn
    raw materials. inwards 
    KRASNOHORSKILKLEKSSREDSTVA, JSC     Russia
  • Buckthorn Buckthorn
    raw materials. inwards 
    HEALTH OF THE FIRM, LLC     Russia
  • Buckthorn Buckthorn
    raw materials. inwards 
    FITOFARM PKF, LLC     Russia
  • Buckthorn extract
    pills inwards 
    VIFITEH, CJSC     Russia
    • Dosage form: & nbspcoated tablets
    Composition:For one tablet:

    Active component

    Krušiny extract is dry with the content of the sum of anthracene derivatives in terms of frangulaemodine and dry matter 2.0%

    0.20 g

    Auxiliary substances of the core

    Potato starch

    0.00625 g

    Calcium stearate

    0.00125 g

    Talc

    0.00125 g

    Sugar (sucrose)

    0.00100 grams

    Sodium bicarbonate

    0.00025 grams

    Shell accessories

    Sugar (sucrose)

    0.09431 g

    Magnesium carbonate basic (magnesium hydroxycarbonate)

    0.01908 g

    Talc

    0.00161 g

    Aerosil (silicon dioxide colloidal)

    0.00160 grams

    Polyvinylpyrrolidone low molecular weight medical (povidone)

    0.00160 grams

    Titanium dioxide

    0.00160 grams

    Vaseline oil (paraffin liquid)

    0.00010 g

    Beeswax

    0.00010 g
    Description:The tablets are round biconvex in shape, covered with a coat, white.
    Pharmacotherapeutic group:Laxative herbal remedy
    ATX: & nbsp

    A.06.A.X   Other laxatives

    Pharmacodynamics:Has a laxative effect, occurring in 8-12 hours. The laxative effect is due to antraglikozidami and chryphonic acid, affecting the receptors of the large intestine and enhancing its peristalsis.
    Pharmacokinetics:No data available.
    Indications:Chronic constipation.
    Contraindications:Hypersensitivity to the components of the drug, acute inflammatory bowel disease (enteritis, colitis), metrorrhagia, constipation of neurogenic and endocrine origin, spastic constipation, intestinal obstruction, acute abdominal syndrome, appendicitis, acute febrile conditions, pregnancy, breastfeeding period, sugar / isomaltase deficiency , intolerance to fructose, glucose-galactose malabsorption, age to 18 years.
    Carefully:

    Diabetes. People on a diet with a low carbohydrate content.

    If you have any of these diseases, consult a doctor before taking the drug.

    Pregnancy and lactation:Contraindicated use of the drug during pregnancy and during breastfeeding.
    Dosing and Administration:

    Inside, 1-2 tablets at bedtime.

    The course of treatment is 1-2 weeks.

    Side effects:

    Allergic reactions are possible (skin rash); a feeling of discomfort in the abdomen (flatulence, spastic pain, nausea).

    If any of these side effects are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:

    Possible colic pain in the abdomen, tenesmus, nausea, vomiting, diarrhea.

    Treatment: symptomatic.

    Interaction:Not described.
    Special instructions:

    It is not recommended to take the product for a long time without consulting a doctor.

    With prolonged use of the drug may develop addiction, in connection with which it is advisable to alternate with other laxatives.

    Patients with diabetes should take into account that one tablet contains about 0.102 g of carbohydrates (0.0085 XE).

    It is possible to stain urine yellow (due to the presence of chrysofic acid), which is not dangerous for the body and does not require the drug to be withdrawn.

    Effect on the ability to drive transp. cf. and fur:The use of the drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
    Form release / dosage:The tablets covered with a cover, 200 mg.
    Packaging:For 10 or 20 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered. 5 contour cell packs of 10 tablets or 1, 2 contour packs of 20 tablets together with instructions for use are placed in a pack of cardboard. 200 contour cell packs of 10 tablets or 100 contour cell packs of 20 tablets together with an equal number of instructions for use are placed in a box or in a cardboard box (for hospitals).
    Storage conditions:

    In a dry, protected from light place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-000289
    Date of registration:17.02.2011 / 30.06.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp24.01.2018
    Illustrated instructions
      Instructions
      Up